Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms
of neurodegeneration in Alzheimer's disease (AD) and related tauopathies. Here, we have …

Although patients with Parkinson's disease (PD) experience pelvic organ dysfunction of the
urinary bladder, bowel and genital organs, an accurate incidence of the dysfunction and its …

A panel of radiochemicals has enabled in vivo positron emission tomography (PET) of tau
pathologies in Alzheimer's disease (AD), although sensitive detection of frontotemporal lobar …

Background Acetylcholinesterase activity, a marker for degeneration of the central cholinergic
system, has consistently been reported, in necropsy brain studies, to be reduced in the …

We measured brain acetylcholinesterase activity in 16 patients with Parkinson's disease (PD),
12 patients with progressive supranuclear palsy (PSP), and 13 age‐matched controls, …

Multiple factors are involved in the development of cognitive impairment in Parkinson's disease
(PD) and related disorders. Notably, several underlying factors, such as monoaminergic …

We measured brain acetylcholinesterase activity in 30 patients with Alzheimer's disease (AD)
and 14 age‐matched controls by positron emission tomography (PET) and using a carbon …

Objective Neuropsychiatric symptoms affect many patients with Alzheimer's disease (AD). (
11 C)Pittsburgh Compound-B (PIB) positron emission tomography (PET) has enabled the in …

Tau accumulation in the brain is a pathologic hallmark of Alzheimer disease and other
tauopathies. Quantitative visualization of tau pathology in humans can be a powerful method as a …

Introduction Amyloid-β (Aβ) and tau accumulations may occur independently and
concurrently as exemplified by primary age-related tauopathy and Alzheimer's disease (AD), …